Abstract
The purpose of this study was to examine the effect of NeuroField pulsed EMF stimulation on Parkinson's Disease (PD) symptoms. Pretreatment, posttreatment, and follow-up QEEG was analyzed along with patient symptom ratings of PD symptoms. The results show significant differences in pre- versus post- versus follow-up QEEG. PD patient symptom ratings were significantly reduced by posttreatment and remained reduced on 30- and 180-day follow-up. NeuroField appears to have potential in reducing PD symptoms.
Acknowledgments
Dr. Dogris is the owner and CEO of NeuroField, Inc.